New Clinical Trials for Ustekinumab & Denosumab Biosimilars Begin Recruitment
Amgen Wins U.S. Patent Battle on Arthritis Drug Enbrel
Canada Approves Erelzi for PsA; Plus FDA Moves to Increase Access to Naloxone
FDA Approves Rituximab Biosimilar; Plus New Safety Data for Filgotinib in RA Patients
EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray
Etanercept Biosimilar Is Effective, Well-Tolerated for Rheumatoid Arthritis
Biosimilars: Still Waiting for Promise to Materialize
Biosimilar SB2 May Work as Well as Infliximab for Rheumatoid Arthritis
Pfizer’s Second Biosimilar of J&J’s Remicade Wins U.S. FDA Approval
- 1
- 2
- 3
- 4
- Next Page »